Stay updated with breaking news from Mitchell Steiner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
19.08.2022 - MIAMI, Aug. 19, 2022 (GLOBE NEWSWIRE) - Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today ... Seite 1
11.08.2022 - -Sabizabulin for COVID-19 Emergency Use Authorization Application Submitted to U.S. FDA in June 2022- -The UK’s Medicines and Healthcare Products Regulatory Agency Informed the Company that its Sabizabulin Marketing Authorization Application Will ...
Veru (VERU) stock is heading higher on Thursday as investors celebrate positive news in its earnings report for fiscal Q3 2022.
Sabizabulin more than halved the risk for death compared with placebo in high-risk, hospitalized adults with COVID-19; the drug company is seeking emergency use okay.
- Phase 3 Clinical Study Met Primary and Key Secondary Endpoints - - Primary Endpoint: Sabizabulin Treatment Showed Statistically Significant and...